Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2005
10/11/2005US6953591 Administering to a mammal non-toxic effective T-cell function-mediated disorder-treating amount of phosphatidyl serine (PS) carrying bodies wherein progression of T-cell function-mediated disorder is inhibited
10/11/2005US6953590 Tape material for transcutaneous absorption
10/11/2005US6953589 Drug delivery device comprising sheets having microstructure projections and rigid supports for applying force and penetrating the skin; medical equipment
10/11/2005US6953586 Bioabsorbable and biocompatible grafts for administered under the skin of animals comprising solid pellets having animal growth regulators such as trenbolone acetate and melengesterol acetate
10/11/2005US6953455 Medicine delivery system
10/11/2005CA2358773C Improved controlled release compositions and method
10/11/2005CA2341949C Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses
10/11/2005CA2315818C Water-soluble eye drop
10/11/2005CA2167921C Biodegradable particles
10/06/2005WO2005093027A1 Compositions with health and nutrition promoting characteristics, containing interestified lipids and phytosterol, and related methods
10/06/2005WO2005092989A1 Particle-stabilised emulsions
10/06/2005WO2005092968A1 Biopolymer compositions and products thereof
10/06/2005WO2005092889A1 Composition for solid pharmaceutical preparation of solifenacin or salt thereof
10/06/2005WO2005092389A1 Composite particle and coated composite particle
10/06/2005WO2005092388A1 Liposome preparation
10/06/2005WO2005092387A1 Stable injectable diclofenac compositions
10/06/2005WO2005092380A2 Uses of anti-ctla-4 antibodies
10/06/2005WO2005092370A1 Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
10/06/2005WO2005092352A1 A Producing Method and Applications of Chinese Medicine Liposome Preparation for Treating Viral Hepatitis B and Preventing and Curing Fibration of Liver Cell
10/06/2005WO2005092347A2 Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle
10/06/2005WO2005092336A1 Controlled-leaching preparation and process for producing the same
10/06/2005WO2005092319A1 Rapidly disintegrating pharmaceutical compositions comprising nateglinide and a disintegrant
10/06/2005WO2005092310A2 Chemically stable compositions of 4-hydroxy tamoxifen
10/06/2005WO2005092301A1 Insulin highly respirable microparticles
10/06/2005WO2005092300A1 Method of making silicone pressure sensitive adhesives for delivering hydrophilic drugs using a silicone polyether
10/06/2005WO2005092299A1 Amorolfine patch for treating onychomycosis
10/06/2005WO2005092298A1 Nanoparticle formulations of platinum compounds
10/06/2005WO2005092297A2 A stable pharmaceutical composition comprising an acid labile drug
10/06/2005WO2005092296A1 Edible microcrystalline cellulose and carrageenan coating composition
10/06/2005WO2005092295A1 Gastroresistant pharmaceutical dosage form comprising n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423)
10/06/2005WO2005092294A1 Oral matrix formulations comprising licarbazepine
10/06/2005WO2005092293A1 Formulations of metformin
10/06/2005WO2005092292A1 Ready mix flavored film coating systems
10/06/2005WO2005092291A1 Prolonged-release compositions comprising torasemide and a matrix-forming polymer
10/06/2005WO2005092290A1 Disintegrating tablets comprising licarbazepine
10/06/2005WO2005092289A1 Dry powder preparations for pre-metered dpi
10/06/2005WO2005092288A1 Carbohydrate-derivatized liposomes for targeting cellular carbohydrate recognition domains of ctl/ctld lectins, and intracellular delivery of therapeutically active compounds
10/06/2005WO2005092287A1 Bioavailable nutritional supplement and method of treatment of malabsorption
10/06/2005WO2005092286A2 Metallic nano-particles and discrete polymer-coated nano-particles
10/06/2005WO2005092272A1 Film products having controlled disintegration properties
10/06/2005WO2005092271A1 Film compositions
10/06/2005WO2005092265A1 Pasting agent
10/06/2005WO2005092264A1 Drug-enhanced adhesion prevention
10/06/2005WO2005092123A1 Solubilized coq-10 and carnitine
10/06/2005WO2005092096A1 Single tank process for preparing tannate liquid and semi-solid dosage forms
10/06/2005WO2005092039A2 Crosslinked amine polymers
10/06/2005WO2005091872A2 Pharmaceutical composition and method for the transdermal delivery of magnesium
10/06/2005WO2005091852A2 Multilayered transdermal drug delivery device
10/06/2005WO2005074699A3 Method for the production of solid dispersions
10/06/2005WO2005072702A3 Method for milling frozen microparticles
10/06/2005WO2005065661A3 Immediate, controlled and sustained release formulations of galanthamine
10/06/2005WO2005054297A3 Cellulose interpolymers and method of oxidation
10/06/2005WO2005039499A3 Rapidly disintegrating film
10/06/2005WO2005034907A8 Skin care topical ointment
10/06/2005WO2005027822A3 Stabilized formulations of phosphatidylserine
10/06/2005WO2005007110A3 Compositions and methods for hydrophobic drug delivery
10/06/2005WO2004108114A3 Anti-fungal composition and a process for its manufacture
10/06/2005WO2004091527B1 Delivery systems of homogeneous thermoreversible low viscosity polymannan gum films
10/06/2005WO2004054702A8 Complex coacervate encapsulate comprising lipophilic core
10/06/2005US20050222645 Microchip-based medical device
10/06/2005US20050222627 Method and apparatus for treating bodily tissues with medicinal substance
10/06/2005US20050222485 System for administering a combination of therapies to a body lumen
10/06/2005US20050222396 Radiolabeled compounds and liposomes and their method of making and using same
10/06/2005US20050222275 Use of dmso in the treatment of neurodegenerative diseases caused by prions
10/06/2005US20050222273 Treatment of female sexual dysfunction
10/06/2005US20050222265 Ophthalmic solution
10/06/2005US20050222264 Anti-rhinovirus active agents
10/06/2005US20050222260 (2S)-2-amino-a-{[2-(ethanimidoylamino) ethyl]thio}butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms
10/06/2005US20050222249 Softgel of NLKJ for treating prostate diseases
10/06/2005US20050222211 S(-)rabeprazole compositions and methods
10/06/2005US20050222205 Treatment of pain with ifendropil
10/06/2005US20050222191 Solution formulations of sirolimus and its analogs for CAD treatment
10/06/2005US20050222182 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
10/06/2005US20050222169 Compositions and methods of treating infections
10/06/2005US20050222116 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue
10/06/2005US20050222111 Method for treating a respiratory disease
10/06/2005US20050222103 Airway alkalinization as therapy for airway diseases
10/06/2005US20050222082 Agent for producing a sensation of safety and for weight loss
10/06/2005US20050222046 Pharmaceutical preparations of glutathione and methods of administration thereof
10/06/2005US20050222006 Aggregates of human insulin derivatives
10/06/2005US20050222001 Stable foamed compositions
10/06/2005US20050221431 Conjugate having a polypeptide targeting moiety including a sequence of human vascular endothelial growth factor, human annexin V, fragment of anthrax lethal factor, or single chain vascular endothelial growth factor covalently bonded via a disulfide bone to a binding moiety such as an adapter protein
10/06/2005US20050220996 Process for coating a pharmaceutical particle
10/06/2005US20050220900 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta
10/06/2005US20050220890 Ion binding compositions
10/06/2005US20050220889 Ion binding compositions
10/06/2005US20050220888 Controlled release compositions and methods for using same
10/06/2005US20050220887 Method for milling frozen microparticles
10/06/2005US20050220886 Immobilized immunomodulators; antiinflammatory, anticarcinogenic agents, antiallergens; autoimmune diseases, asthma
10/06/2005US20050220885 Manufacture of strong, lightweight carrier granules
10/06/2005US20050220884 Free-flowing, powdery composition containing alpha-liponic acid (derivates)
10/06/2005US20050220883 Microparticles with adsorbed polypeptide-containing molecules
10/06/2005US20050220882 Materials for medical implants and occlusive devices
10/06/2005US20050220880 Drug carriers comprising amphiphilic block copolymers
10/06/2005US20050220879 Dosage forms having a barrier layer to laser ablation
10/06/2005US20050220878 Enteric coatings for orally ingestible substrates
10/06/2005US20050220877 Bilayer tablet comprising an antihistamine and a decongestant
10/06/2005US20050220876 Methods and composition of extended delivery of water insoluble drugs
10/06/2005US20050220875 Sustained-release tablet formulation
10/06/2005US20050220874 Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonist
1 ... 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 ... 2991